Literature DB >> 18522644

Characterization of osteopontin expression and function after status epilepticus.

Karin Borges1, Marla Gearing, Susan Rittling, Esben S Sorensen, Robert Kotloski, David T Denhardt, Raymond Dingledine.   

Abstract

PURPOSE: Osteopontin is a cytokine found in many tissues and plays a role in tissue injury and repair. This study had two goals: to characterize osteopontin expression after status epilepticus (SE), and to test the hypotheses that osteopontin affects the susceptibility to seizures or alters cell death and inflammation after SE.
METHODS: Pilocarpine was used to induce SE in OPN(-/-) and OPN(+/+) mice to compare seizure susceptibility, neuropathological markers including real time PCR for inflammatory genes, and osteopontin immunohistochemistry. The effect of added osteopontin on excitotoxicity by N-methyl-d-aspartate in neuronal cultures of ONP(-/-) mice was determined.
RESULTS: Neurons undergoing degeneration showed osteopontin immunoreactivity 2-3 days after SE. After 10 to 31 days degenerating axons in the thalamus were osteopontin-positive. The susceptibility to seizures of OPN(-/-) and OPN(+/+) mice in the pilocarpine, fluorothyl, and maximal electroshock models was similar. There were no significant differences in the extent of neuronal damage after pilocarpine-induced SE, the expression of several neuropathological markers or the RNA levels of selected inflammatory genes. Recombinant and natural bovine osteopontin did not affect the extent of NMDA-induced cell death in OPN(-/-) mouse neuronal cultures.
CONCLUSION: We demonstrated that osteopontin is up-regulated in response to SE in distinct temporal sequences in the hippocampus, specifically in degenerating neurons and axons. However, osteopontin did not appear to regulate neurodegeneration or inflammation within the first 3 days after SE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522644      PMCID: PMC4090704          DOI: 10.1111/j.1528-1167.2008.01613.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  39 in total

1.  Osteopontin-immunoreactivity in the rat trigeminal ganglion and trigeminal sensory nuclei.

Authors:  H Ichikawa; K Yamashita; T Takano-Yamamoto; T Sugimoto
Journal:  Brain Res       Date:  2001-11-16       Impact factor: 3.252

Review 2.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.

Authors:  R Zohar; N Suzuki; K Suzuki; P Arora; M Glogauer; C A McCulloch; J Sodek
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

4.  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Authors:  D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

Review 5.  Role of osteopontin in cellular signaling and toxicant injury.

Authors:  D T Denhardt; C M Giachelli; S R Rittling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

6.  Use of suppression subtractive hybridization for differential gene expression in stroke: discovery of CD44 gene expression and localization in permanent focal stroke in rats.

Authors:  H Wang; Y Zhan; L Xu; G Z Feuerstein; X Wang
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

Review 7.  Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.

Authors:  Marta Scatena; Lucy Liaw; Cecilia M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

8.  Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.

Authors:  Ulrich Ebert; Claudia Brandt; Wolfgang Löscher
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

9.  Osteopontin in kainic acid-induced microglial reactions in the rat brain.

Authors:  Seong Yun Kim; Yun-Sik Choi; Jeong-Sun Choi; Jung-Ho Cha; Ok Nyu Kim; Sang Bok Lee; Jin-Woong Chung; Myung-Hoon Chun; Mun-Yong Lee
Journal:  Mol Cells       Date:  2002-06-30       Impact factor: 5.034

10.  Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice.

Authors:  Veerle P Persy; Anja Verhulst; Dirk K Ysebaert; Kathleen E De Greef; Marc E De Broe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

View more
  9 in total

1.  Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Authors:  Julie L Chan; Thomas M Reeves; Linda L Phillips
Journal:  Exp Neurol       Date:  2014-08-21       Impact factor: 5.330

2.  Progressive secondary neurodegeneration and microcalcification co-occur in osteopontin-deficient mice.

Authors:  Walter Maetzler; Daniela Berg; Claudia Funke; Freya Sandmann; Holger Stünitz; Corina Maetzler; Cordula Nitsch
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

3.  Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.

Authors:  Yin-Chuan Jin; Hahnbie Lee; Seung-Woo Kim; Il-Doo Kim; Hye-Kyung Lee; Yunjin Lee; Pyung-Lim Han; Ja-Kyeong Lee
Journal:  Mol Neurobiol       Date:  2015-10-19       Impact factor: 5.590

4.  Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.

Authors:  Sarah Willis; James Stoll; Lawrence Sweetman; Karin Borges
Journal:  Neurobiol Dis       Date:  2010-08-04       Impact factor: 5.996

Review 5.  Gene expression profiling as a tool to investigate the molecular machinery activated during hippocampal neurodegeneration induced by trimethyltin (TMT) administration.

Authors:  Wanda Lattanzi; Valentina Corvino; Valentina Di Maria; Fabrizio Michetti; Maria Concetta Geloso
Journal:  Int J Mol Sci       Date:  2013-08-15       Impact factor: 5.923

6.  Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy.

Authors:  Vera Russmann; Matthias Brendel; Erik Mille; Angela Helm-Vicidomini; Roswitha Beck; Lisa Günther; Simon Lindner; Axel Rominger; Michael Keck; Josephine D Salvamoser; Nathalie L Albert; Peter Bartenstein; Heidrun Potschka
Journal:  Neuroimage Clin       Date:  2017-04-05       Impact factor: 4.881

7.  Spatiotemporal expression of osteopontin in the striatum of rats subjected to the mitochondrial toxin 3-nitropropionic acid correlates with microcalcification.

Authors:  Tae-Ryong Riew; Hong Lim Kim; Xuyan Jin; Jeong-Heon Choi; Yoo-Jin Shin; Ji Soo Kim; Mun-Yong Lee
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

8.  RNAseq analysis of hippocampal microglia after kainic acid-induced seizures.

Authors:  Dale B Bosco; Jiaying Zheng; Zhiyan Xu; Jiyun Peng; Ukpong B Eyo; Ke Tang; Cheng Yan; Jun Huang; Lijie Feng; Gongxiong Wu; Jason R Richardson; Hui Wang; Long-Jun Wu
Journal:  Mol Brain       Date:  2018-06-20       Impact factor: 4.041

9.  Neuronal and glial DNA methylation and gene expression changes in early epileptogenesis.

Authors:  Toni C Berger; Magnus D Vigeland; Hanne S Hjorthaug; Lars Etholm; Cecilie G Nome; Erik Taubøll; Kjell Heuser; Kaja K Selmer
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.